POLYMEDNSEPoly Medicure Limited· PharmaceuticalsMediumNeutral
Announced Fri, 26 Jun · 18:10 IST

CRISIL revises Poly Medicure outlook to Positive; rating reaffirmed

Rating UpgradedNew Credit FacilityCredit & Debt View source PDF

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹1650.00
prior close
₹1650.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-1.2-0.9-0.0+2.1+0.9+5.1+2.1+2.1-2.1+3.6
Up moveDown movePending
AI summary

CRISIL Ratings has revised the outlook on Poly Medicure's long term bank facility rating to Positive from Stable, while reaffirming the rating at AA-. The short term rating is also reaffirmed at A1+. Total bank loan facilities rated stand enhanced at Rs 500 crore, up from Rs 400 crore earlier, spread across SBI, HSBC, HDFC Bank, and Citibank for fund based and non-fund based limits.

Likely market impact

Positive outlook signals possible future upgrade; higher credit limit of Rs 500 crore (from Rs 400 crore) reflects stronger lender confidence in the company.